Chargement en cours...
Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance
BACKGROUND: Advanced prostate cancer is currently treated with androgen deprivation therapy (ADT). ADT initially results in tumor regression, however, all patients eventually relapse with castration-resistant prostate cancer. New approaches to delay the progression of prostate cancer to castration r...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3319476/ https://ncbi.nlm.nih.gov/pubmed/22161776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22458 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|